Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity

Biochemical Pharmacology

Volumn 66, Issue 12, 2003, Pages 2323-2331

  Leu, Tzeng Horng ^a   Su, Shu Li ^b   Chuang, Ya Chun ^a   Maa, Ming Chei ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Curcumin; ERK; FAK; Migration; Shc; Src

Indexed keywords

CORTACTIN; CURCUMIN; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE P60;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0344962391     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.08.017     Document Type: Article

References (37)

1. Govindarajan V.S. Turmeric-chemistry, technology, and quality. Crit. Rev. Food Sci. Nutr. 12:1980;199-301.
2. Leu T.-H., Maa M.-C. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr. Med. Chem-Anti-Cancer Agent. 2:2002;357-370.
3. Robinson D.R., Wu Y.M., Lin S.F. The protein tyrosine kinase family of the human genome. Oncogene. 19:2000;5548-5557.
4. Biscardi J.S., Tice D.A., Parsons S.J. c-Src, receptor tyrosine kinases, and human cancer. Adv. Cancer Res. 76:1999;61-119.
5. Leu T.-H., Maa M.-C. Functional implication of the interaction between EGF receptor and c-Src. Front Biosci. 8:2003;s28-s38.
6. Kanner S.B., Reynolds A.B., Vines R.R., Parsons J.T. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc. Natl. Acad. Sci. U.S.A. 7:1990;3328-3332.
7. src substrate. Mol. Cell Biol. 11:1991;5113-5124.
8. c-src substrate. Oncogene. 7:1992;2429-2438.
9. McGlade J., Cheng A., Pelicci P.G., Pawson T. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein tyrosine kinases. Proc. Natl. Acad. Sci. U.S.A. 89:1992;8869-8873.
10. Salcini A.E., McGlade J., Pelicci G., Nicoletti I., Pawson T., Pelicci P.G. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene. 9:1994;2827-2836.
11. Wary K.K., Mariotti A., Zurzolo C., Giancotti F.G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 94:1998;625-634.
12. Parsons J.T., Martin K.H., Slack J.K., Taylor J.M., Weed S.A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene. 19:2000;5606-5613.
13. FAK. Mol. Cell Biol. 14:1994;147-155.
14. src. Mol. Cell Biol. 14:1994;1680-1688.
15. Calalb M.B., Polte T.R., Hanks S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell Biol. 15:1995;954-963.
16. Maa M.-C., Leu T.-H. Vanadate-dependent FAK activation is accomplished by the sustained FAK Tyr-576/577 phosphorylation. Biochem. Biophys. Res. Commun. 251:1998;344-349.
17. Leu T.-H., Maa M.-C. Tyr-863 phosphorylation enhances focal adhesion kinase autophosphorylation at Tyr-397. Oncogene. 21:2002;6992-7000.
18. Schlaepfer D.D., Hanks S.K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786-791.
19. Korutla L., Cheung J.Y., Mendelsohn J., Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis. 16:1995;1741-1745.
20. neu. Clin. Cancer Res. 5:1999;1884-1891.
21. c-src. Mol. Cell Biol. 8:1988;497-501.
22. Maa M.-C., Lai J.R., Lin R.W., Leu T.-H. Enhancement of tyrosyl phosphorylation and protein expression of eps8 by v-Src. Biochim. Biophys. Acta. 1450:1999;341-351.
23. Wang F., Van Brocklyn J.R., Hobson J.P., Movafagh S., Zukowska-Grojec Z., Milstien S., Spiegel S. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274:1999;35343-35350.
24. Sturgill T.W., Ray L.B., Erikson E., Maller J.L. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 334:1988;715-718.
25. Payne D.M., Rossomando A.J., Martino P., Erickson A.K., Her J.H., Shabanowitz J., Hunt D.F., Weber M.J., Sturgill T.W. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:1991;885-892.
26. Huang M.T., Ma W., Lu Y.P., Chang R.L., Fisher C., Manchand P.S., Newmark H.L., Conney A.H. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13- acetate-induced tumor promotion. Carcinogenesis. 16:1995;2493-2497.
27. Dinkova-Kostova A.T., Talalay P. Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Carcinogenesis. 20:1999;911-914.
28. Venkatesan P., Rao M.N. Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues. J. Pharm. Pharmacol. 52:2000;1123-1128.
29. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
30. Huang C., Liu J., Haudenschild C.C., Zhan X. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J. Biol. Chem. 270:1998;25570-25576.
31. Santibanez J.F., Quintanilla M., Martinez J. Genistein and curcumin block TGF-beta 1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal keratinocytes. Nutr. Cancer. 37:2000;49-54.
32. Mirnics K., Middleton F.A., Lewis D.A., Levitt P. Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24:2001;479-486.
33. Mariadason J.M., Corner G.A., Augenlicht L.H. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 60:2000;4561-4572.
34. Soni K.B., Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. J. Physiol. Pharmacol. 36:1992;273-275.
35. Rao C.V., Rivenson A., Simi B., Zang E., Hamid R., Kelloff G.J., Steele V., Reddy B.S. Enhancement of experimental colon carcinogenesis by dietary 6-phenylhexyl isothiocyanate. Cancer Res. 55:1995;4311-4318.
36. FAK) in invasive human tumors. Cancer Res. 55:1995;2752-2755.
37. Agochiya M., Brunton V.G., Owens D.W., Parkinson E.K., Paraskeva C., Keith W.N., Frame N.C. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene. 18:1999;5646-5653.